Nevro Corp
(NYSE:NVRO)
$
5.06
-0.26 (-4.89%)
Market Cap: 188.65 Mil
Enterprise Value: 166.94 Mil
PE Ratio: 0
PB Ratio: 0.69
GF Score: 42/100 
Nevro Corp at Bank of America Global Healthcare Conference Transcript
May 11, 2023 / 12:00AM GMT
Release Date Price:
$27.11
(-3.01%)
Operator
I'm Travis Steed, Medical Device Analyst at Bank of America. And up next, we have Nevro Corporation. We've got Kevin Thornal, Chief Executive Officer, first time at a conference, so thank you for coming. And got Rod, CFO; and of course, Julie Dewey as well. Thanks for coming. I hope, my mic is on. I'm sure.
Okay. So maybe, Keith, just...
Kevin R. Thornal
Nevro Corp. - President, CEO & Director
Kevin.
Julie D. Dewey
Nevro Corp. - Chief Corporate Communications & IR Officer
I swear.
Travis Lee Steed
BofA Securities, Research Division - MD
The previous CEO was Keith, I see that, sorry. So I was just reading, sorry about that Kevin.
Julie D. Dewey
Nevro Corp. - Chief Corporate Communications & IR Officer
Those of you who know me, it was like that. I said, no, no, no. Here's his name.
Kevin R. Thornal
Nevro Corp. - President, CEO & Director
It's all right.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers